ABT
Abbott Laboratories
Medical Devices · Healthcare · United States
104.57
close · 2026-10-29
value
76
cheaper than peers76
quality
81
stronger fundamentals81
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| cash flow yield, 3 years ago | 4.1% | 86 |
| earnings yield, 1 year ago | 6.9% | 86 |
| earnings yield, 2 years ago | 2.9% | 86 |
| earnings yield, latest year | 3.3% | 77 |
| earnings yield, 3 years ago | 3.5% | 77 |
| cash flow yield, 2 years ago | 2.6% | 77 |
| cash flow yield, 1 year ago | 3.3% | 77 |
| forward P/E | 17.61× | 70 |
| cash flow yield, latest year | 3.8% | 59 |
| price to book | 3.54× | 45 |
| EV to EBITDA | 17.55× | 42 |
| price to sales | 3.73× | 36 |
12 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 14.7% | 85 |
| return on equity | 10.6% | 78 |
| revenue growth | 13.0% | 60 |
| debt to equity | 63.2% | 43 |
4 of 4 measures available
Facts
| market cap | $181B |
| free cash flow | $7.21B |
| employees | 122,000 |
| first trade | 1980-03-17 |
| next earnings | 2026-10-21 |
| fundamentals updated | 2026-10-21 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 3.72 | 7.64 | 3.26 | 3.91 |
| free cash flow | $7.39B | $6.35B | $5.06B | $7.80B |
| net income | $6.52B | $13.40B | $5.72B | $6.93B |
| revenue | $44.33B | $41.95B | $40.11B | $43.65B |
| unusual items | $50.0M | $27.0M | -$41.0M | -$2.0M |